Jay Keasling, CEO for JBEI and a leading authority on synthetic biology who has engineered microbial “factories” to manufacture a frontline antimalarial drug and biofuel substitutes for gasoline, diesel and jet fuel, has won a 2012 Heinz Award. Presented by the Heinz Family Foundation, the award carries with it a medallion and a cash prize of $250,000.